Variant report
Variant | nsv824815 |
---|---|
Chromosome Location | chr9:1200679-1201120 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188513036 | chr9:1200695-1200696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10960363 | chr9:1200703-1200704 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs535549880 | chr9:1200737-1200738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139215840 | chr9:1200764-1200765 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12336853 | chr9:1200771-1200772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537469144 | chr9:1200775-1200776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs868085 | chr9:1200784-1200785 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs577899178 | chr9:1200821-1200822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114844183 | chr9:1200839-1200840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545891016 | chr9:1200871-1200872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs180891379 | chr9:1200897-1200898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542729413 | chr9:1200898-1200899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562877536 | chr9:1200917-1200918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576460490 | chr9:1200919-1200920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545120751 | chr9:1200941-1200942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12341136 | chr9:1200946-1200947 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs114085627 | chr9:1201011-1201012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548064928 | chr9:1201017-1201018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143331940 | chr9:1201021-1201022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530350088 | chr9:1201030-1201031 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116873201 | chr9:1201056-1201057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568904185 | chr9:1201064-1201065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs867579 | chr9:1201091-1201092 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs147525787 | chr9:1201113-1201114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1198800-1200800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr9:1198800-1202600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
3 | chr9:1200000-1203600 | Enhancers | Liver | Liver |
4 | chr9:1200400-1201400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
5 | chr9:1200600-1201600 | Enhancers | Esophagus | oesophagus |
6 | chr9:1200600-1201600 | Enhancers | Fetal Lung | lung |
7 | chr9:1200600-1201600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr9:1200600-1201800 | Enhancers | HepG2 | liver |
9 | chr9:1200600-1202200 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr9:1200600-1202200 | Enhancers | Pancreas | Pancrea |
11 | chr9:1200600-1203000 | Enhancers | Psoas Muscle | Psoas |
12 | chr9:1200800-1201200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr9:1200800-1201400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr9:1201000-1201600 | Enhancers | Adipose Nuclei | Adipose |
15 | chr9:1201000-1201600 | Enhancers | Gastric | stomach |
16 | chr9:1201000-1202000 | Enhancers | Fetal Brain Male | brain |
17 | chr9:1201000-1202000 | Enhancers | Fetal Muscle Trunk | muscle |
18 | chr9:1201000-1202000 | Enhancers | Lung | lung |
19 | chr9:1201000-1202200 | Enhancers | Left Ventricle | heart |